Form 4 for MED MEDIFAST INC
Accepted 2022-02-24 00:00:00 ET · period of report 2022-02-22 · accession 0001104659-22-026864 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-02-24 | 2022-02-22 | MED | Chard Daniel R | COB, CEO, Dir | F - Tax | $177.06 | -3,086 | 12.6K | -20% | -$546.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-22 | F | D | 1,804 | $177.06 | 13,912 | D | — | — | (F1) These shares vested on February 19, 2022, which fell on a weekend. The settlement date of this vesting and subsequent withholding fell on the following business day, February 22, 2022. (F2) Pursuant to the terms of the Issuer's Amended and Restated 2012 Share Incentive Plan, the price was the closing sales price for the most recent trading day prior to the vesting date. |
| 2 | Common | Common Stock | 2022-02-22 | F | D | 1,282 | $177.06 | 12,630 | D | — | — | (F3) These shares vested on February 20, 2022, which fell on a weekend. The settlement date of this vesting and subsequent withholding fell on the following business day, February 22, 2022. (F2) Pursuant to the terms of the Issuer's Amended and Restated 2012 Share Incentive Plan, the price was the closing sales price for the most recent trading day prior to the vesting date. |